Effect of Teriflunomide on Cells From Patients With Human T-cell Lymphotropic Virus Type 1–Associated Neurologic Disease

OBJECTIVE: To test the hypothesis that teriflunomide can reduce ex vivo spontaneous proliferation of peripheral blood mononuclear cells (PBMCs) from patients with human T-cell lymphotropic virus type 1 (HTLV-1)–associated myelopathy/tropical spastic paraparesis (HAM/TSP). METHODS: PBMCs from patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Enose-Akahata, Yoshimi, Ngouth, Nyater, Ohayon, Joan, Mandel, Matt, Chavin, Jeffrey, Turner, Timothy J., Jacobson, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054963/
https://www.ncbi.nlm.nih.gov/pubmed/33837058
http://dx.doi.org/10.1212/NXI.0000000000000986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054963/
https://www.ncbi.nlm.nih.gov/pubmed/33837058
http://dx.doi.org/10.1212/NXI.0000000000000986

Ejemplares similares